Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Robbins & Myers, Inc. (NYSE: RBN) arising from its agreement for Robbins & Myers to be acquired by National Oilwell Varco Inc. in a transaction valued at approximately $2.54 billion. Under the terms of the agreement, Robbins & Myers’s shareholders will receive $60 in cash for each share of Robbins & Myers stock at closing.
Weiss & Lurie is investigating whether Robbins & Myers’s Board acted in the best interests of shareholders in approving this deal. Multiple analysts have set a target price for Robbins & Myers stock above $60, with a high target set at $72. Moreover, Robbins & Myers’s Board has agreed to coercive deal protection devices including a “no shop” provision and a provision that requires Robbins & Myers to pay National Oilwell’s expenses, up to $50 million, if Robbins & Myers’s shareholders fail to approve the Merger Agreement. If you own Robbins & Myers shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Michael A. Rogovin either by telephone at (888) 593-4771 or by email at
Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at
or fill out the form on our website,
Attorney Advertising. Past results do not guarantee a similar outcome.